We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Hemosonics - A Stago Company

HemoSonics is a medical device company developing a point-of-care diagnostic platform to guide the management of crit... read more Featured Products: More products

Download Mobile App




POC Hemostasis System Could Help Prevent Maternal Deaths

By LabMedica International staff writers
Posted on 27 Dec 2024
Print article
Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)
Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)

Postpartum hemorrhage (PPH), which refers to severe bleeding following childbirth, is the leading cause of maternal deaths globally. Every year, about 14 million women experience PPH, and approximately 70,000 die as a result. This issue is not limited to developing countries, as the United States reports 21.1 deaths per 100,000 live births, nearly double the average in countries belonging to the Organization for Economic Cooperation and Development (OECD), with over 10% of maternal deaths attributed to excessive bleeding. Now, new research is exploring how a novel hemostasis system could potentially improve the management of peripartum bleeding in obstetric patients.

HemoSonics (Durham, NC, USA) is researching the role of its Quantra Hemostasis System in enhancing the management of peripartum bleeding. The system includes the Quantra Hemostasis Analyzer, equipped with QPlus and QStat Cartridges, which provide clinicians with valuable data to guide patient-centered decisions regarding bleeding control, improving care and optimizing blood product use. The Quantra System utilizes SEER Sonorheometry (Sonic Estimation of Elasticity via Resonance), a proprietary ultrasound technology that assesses the coagulation properties of whole blood samples.

This system is easy to maintain, simple to operate and interpret, and offers rapid, comprehensive whole-blood coagulation analysis in under 15 minutes, whether at the point of care or in laboratory settings. The Quantra System is FDA-cleared for use in cardiovascular surgeries, trauma, liver transplants, and major orthopedic procedures. It helps hospitals standardize their viscoelastic testing processes in a clinically efficient and operationally effective manner. Recently, HemoSonics was selected as one of the final winners for the RADx Tech for Maternal Health Challenge from over 80 submissions for efforts to improve postpartum maternal health and health equity with innovative diagnostic tools.

“It is a tremendous validation to receive the RADx award and recognition from NIH to help support research for how the Quantra Hemostasis System may help obstetric patients,” said HemoSonics’ President and CEO Bob Roda. “Along with the other winners, HemoSonics will work tirelessly to advance technologies that help women have safe and healthy deliveries, wherever they may live, and to improve overall maternal health.”

Related Links:
HemoSonics

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.